EBITDA: Income before interest, taxes, depreciation and amortization.
Basel Medical Group Ltd (BMGL) had EBITDA of $-0.82M for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$8.90M |
|
$-9.50M |
|
$1.99M |
|
$6.91M |
|
$9.81M |
|
$-0.91M |
|
$-8.92M |
|
$-9.83M |
|
$-1.07M |
|
$-9.50M |
|
$-9.50M |
|
$-9.50M |
|
$-0.45M |
|
$-0.91M |
|
|
EBITDA |
$-0.82M |
18.79M |
|
18.79M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$10.31M |
|
$0.22M |
|
$2.94M |
|
$13.25M |
|
$8.41M |
|
$1.02M |
|
$1.02M |
|
$9.43M |
|
$3.82M |
|
$3.82M |
|
$3.82M |
|
18.79M |
|
| Cash Flow Statement Financials | |
$-3.42M |
|
$-8.68M |
|
$13.29M |
|
$1.53M |
|
$2.34M |
|
$0.81M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
0.21 |
|
0.70 |
|
77.68% |
|
-10.21% |
|
-10.21% |
|
-9.26% |
|
-110.47% |
|
-106.78% |
|
$-3.46M |
|
-- |
|
-- |
|
-- |
|
0.67 |
|
6.71 |
|
1.16 |
|
313.78 |
|
-248.49% |
|
-248.49% |
|
-71.72% |
|
-196.14% |
|
$0.20 |
|
$-0.18 |
|
$-0.18 |
|